
Bitfount revolutionizes clinical trial recruitment by using federated learning to access hard-to-reach patient populations without sharing sensitive data, accelerating drug development
Bitfount presents an exciting opportunity to revolutionize patient recruitment for clinical trials, addressing a $30B+ global problem with substantial implications for the speed and cost of drug development. By applying federated learning, they enable hospitals and clinics to run AI models locally on imaging and health data without sharing sensitive information, unlocking access to hard-to-reach patient populations. Their initial traction in ophthalmology—where they've demonstrated the ability to recruit exponentially more patients for trials—positions them well for scalability into oncology, cardiology, and beyond. With a strong team, pharma buy-in, and a viable business model, they are poised to disrupt the future of trial recruitment
AI, Deep Tech, Pharma, Personalized Care, Ophthalmology